Early Breast Cancer Trialists’ Collaborative Group18
|
Breast cancer: ductal carcinoma in situ |
Surgery+adjuvant radiotherapy versus surgery alone |
12 |
1 (8) |
Early Breast Cancer Trialists’ Collaborative Group19
|
Breast cancer: metastatic |
Surgery+adjuvant chemotherapy versus surgery alone |
7 |
2 (29) |
Dowsett et al20
|
Breast cancer: oestrogen receptor poor |
Adjuvant aromatase inhibitors (with or without tamoxifen) versus tamoxifen alone |
15 |
3 (20) |
Piccart-Gebhart et al21
|
Breast cancer |
Taxanes alone, or in combination with anthracyclines |
6 |
1 (17) |
Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration22
|
Cervical cancer |
Concomitant chemoradiotherapy versus radiotherapy |
6 |
5 (83) |
Eden et al23
|
Childhood acute lymphoblastic leukaemia |
Vincristine+steroid pulses versus maintenance treatment |
1 |
0 (0) |
Childhood Acute Lymphoblastic Leukaemia Collaborative Group24
|
Childhood acute lymphoblastic leukaemia |
Anthracyclines+standard therapy versus standard therapy |
1 |
0 (0) |
Uronis et al25
|
Dyspnoea (in cancer) |
Oxygen versus medical air |
1 |
0 (0) |
Baujat et al26
|
Head and neck cancer: locally advanced |
Conventional radiotherapy versus hyperfractionated radiotherapy or accelerated radiotherapy, or both |
8 |
4 (50) |
Pignon et al27
|
Head and neck cancer: locally advanced |
Locoregional treatment+chemotherapy versus locoregional treatment alone |
8 |
6 (75) |
Greb et al28
|
Non-Hodgkin’s lymphoma |
High dose chemotherapy with autologous stem cell transplantation versus standard dose chemotherapy |
8 |
4 (50) |
Auperin et al29
|
Non-small cell lung cancer: locally advanced |
Concomitant versus sequential chemoradiotherapy |
13 |
7 (54) |
NSCLC Meta-analysis Collaborative Group30
|
Non-small cell lung cancer |
Locoregional treatment+adjuvant chemotherapy versus locoregional treatment alone |
15 |
3 (20) |
NSCLC Meta-analysis Collaborative Group31
|
Non-small cell lung cancer: advanced |
Chemotherapy+ supportive care versus supportive care alone |
6 |
1 (17) |
De Luca et al32
|
Angioplasty |
Glycoprotein IIb-IIIa inhibitors administered early versus late |
1 |
0 (0) |
Bejan-Angoulvant et al33
|
Hypertension |
Active treatment versus no treatment or placebo |
3 |
1 (33) |
De Backer Tine et al34
|
Intermittent claudication |
Oral naftidrofuryl versus placebo |
2 |
0 (0) |
Cholesterol Treatment Trialists’ Collaboration35
|
Low density lipoprotein cholesterol lowering in cardiovascular disease prevention |
Statins versus control; more intensive versus less intensive statin regimens |
14 |
6 (43) |
Antithrombotic Trialists’ Collaboration36
|
Primary and secondary prevention of cardiovascular disease |
Long term aspirin versus control |
16 |
14 (88) |
Halkes et al37
|
Secondary prevention of stroke |
Dipyridamole+aspirin versus aspirin |
5 |
1 (20) |
Craig et al38
|
Stroke |
Very early mobilisation versus usual stroke care |
3 |
0 (0) |
Ellis et al39
|
Stroke |
Stroke liaison workers versus usual stroke care |
4 |
1 (25) |
Browning et al40
|
Otitis media in children |
Grommet insertion versus myringotomy or non-surgical treatment |
0 |
Not applicable |
Koopman et al41
|
Otitis media in children |
Antibiotic treatment versus placebo or no (antibiotic) treatment |
0 |
Not applicable |
Kassai et al42
|
Severe myoclonic epilepsy in infancy |
Stiripentol versus placebo |
1 |
0 (0) |
Ford et al43
|
Dyspepsia |
Helicobacter pylori “test and treat” versus empirical acid suppression |
2 |
1 (50) |
Daniels et al44
|
Gynaecological: chronic pelvic pain |
Laparoscopic uterosacral nerve ablation (LUNA) versus diagnostic laparoscopy or laparoscopic excision or ablation |
0 |
No applicable |
Middleton et al45
|
Gynaecological: heavy menstrual bleeding |
Hysterectomy versus endometrial destruction (1st or 2nd generation) or levonongesterol releasing intrauterine system (MIRENA); endometrial destruction versus MIRENA; 1st versus 2nd generation endometrial destruction |
1 |
1 (100) |
Cools et al46
|
Neonatal care: preterm infants |
Elective high frequency oscillatory versus conventional ventilation |
0 |
Not applicable |
Cates et al47
|
Asthma |
Regular treatment with salmeterol versus placebo or regular short acting β agonists |
5 |
1 (20) |
Young et al48
|
Rhinosinusitis |
Antibiotic treatment versus placebo |
3 |
1 (33) |
Wang et al49
|
Smoking cessation |
Nicotine replacement therapy versus placebo |
7 |
0 (0) |
O’Meara et al50
|
Venous leg ulcers: wound care |
Four layer versus short stretch bandage |
3 |
2 (67) |